Professor of Psychiatry, Massachusetts General Hospital
Psychiatry
Dr. Andrew A. Nierenberg, MD
|
|
Give Review
Doctor Andrew A. Nierenberg, MD practices Psychiatry. He studied medicine at NYU School of Medicine. Andrew Nierenberg is a published physician. He published 101 publications, including: 'A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder.' He is registered with Medicare.
Publications
- Relationship between placebo response rate and clinical trial outcome in Bipolar depression.
- A tool to predict suicidal ideation and behavior in bipolar Disorder: The Concise Health Risk Tracking Self-Report.
- A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use Disorders in bipolar Disorder.
- Medical burden, body mass index and the outcome of psychosocial interventions for Bipolar depression.
- Anxiety symptoms are linked to new-onset suicidal ideation after six months of follow-up in outpatients with major depressive Disorder.
- Medical burden in bipolar Disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE).
- Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive Disorder: a proof-of-concept study.
- Family functioning in the context of parental bipolar Disorder: associations with offspring age, sex, and psychopathology.
- Psychotherapy use in bipolar Disorder: Association with functioning and illness severity.
- Complexity of Illness and Adjunctive Benzodiazepine Use in Outpatients With Bipolar I or II Disorder: Results From the Bipolar CHOICE Study.
- Eating behavior and obesity in bipolar Disorder.
- Age at onset, course of illness and response to psychotherapy in bipolar Disorder: results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP...
- The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar Disorder.
- Predictors of placebo response in Bipolar depression.
- The effects of co-morbidity in defining Major depression subtypes associated with long-term course and severity.
- Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood Disorders.
- A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression.
- Corrigendum to "Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II Disorder: Results from the...
- Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II Disorder: results from the Bipolar CHOICE ...
- Clinical applications of herbal medicines for anxiety and insomnia; targeting patients with bipolar Disorder.
- Correlates of real world executive dysfunction in bipolar I Disorder.
- A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trial.
- EPIDEMIOLOGY AND COURSE OF UNIPOLAR MANIA: RESULTS FROM THE NATIONAL EPIDEMIOLOGIC SURVEY ON ALCOHOL AND RELATED CONDITIONS (NESARC).
- EARLY RISK FACTORS FOR PSYCHOPATHOLOGY IN OFFSPRING OF PARENTS WITH BIPOLAR Disorder: THE ROLE OF OBSTETRIC COMPLICATIONS AND MATERNAL COMORBID ANXIETY.
- Extreme attributions predict suicidal ideation and suicide attempts in bipolar Disorder: prospective data from STEP-BD.
- A Novel Home Sleep Monitoring Device and Brief Sleep Intervention for Bipolar Disorder: Feasibility, Tolerability, and Preliminary Effectiveness.
- Strategies for achieving full remission when first-line antidepressants are not enough.
- Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): A pragmatic trial of complex treatment for a complex Disorder.
- Nutrition, Exercise, and Wellness Treatment in bipolar Disorder: proof of concept for a consolidated intervention.
- Medication adherence in a comparative effectiveness trial for bipolar Disorder.
- Extreme attributions predict transition from depression to mania or hypomania in bipolar Disorder.
- Conditional Probability of Response or Nonresponse of Placebo Compared With Antidepressants or St John's Wort in Major Depressive Disorder.
- Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar Disorder.
- Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood Disorders.
- One-carbon metabolism and bipolar Disorder.
- Adverse clinical events among medicare beneficiaries using antipsychotic drugs: linking health insurance benefits and clinical needs.
- Smoking and suicidality in subjects with major depressive Disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
- Lithium tremor revisited: pathophysiology and treatment.
- Using comparative effectiveness design to improve the generalizability of Bipolar treatment trials data: Contrasting LiTMUS baseline data with pre-existing placebo con...
- The Medication Recommendation Tracking Form: A novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness...
- A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive Disorder.
- Increase in work productivity of depressed individuals with improvement in Depressive symptom severity.
- Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS).
- SMOKING AND SUICIDALITY IN SUBJECTS WITH BIPOLAR Disorder: RESULTS FROM THE NATIONAL EPIDEMIOLOGIC SURVEY ON ALCOHOL AND RELATED CONDITIONS (NESARC).
- Association Between Therapeutic Alliance, Care Satisfaction, and Pharmacological Adherence in Bipolar Disorder.
- Extreme attributions predict the course of Bipolar depression: results from the STEP-BD randomized controlled trial of psychosocial treatment.
- General medical burden in bipolar Disorder: findings from the LiTMUS comparative effectiveness trial.
- Clinical and sociodemographic characteristics associated with suicidal ideation in depressed outpatients.
- Lithium treatment moderate-dose use study (LiTMUS) for bipolar Disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and with...
- Andrew C leon.
- The absence of Depressive symptoms is not the presence of wellness: Validation of the Clinical Positive Affect Scale.
- Nutrient-based therapies for bipolar Disorder: a systematic review.
- An exploratory study of combination buspirone and melatonin SR in Major Depressive Disorder (MDD): A possible role for neurogenesis in drug discovery.
- Transdiagnostic treatment of bipolar Disorder and comorbid anxiety with the unified protocol: a clinical replication series.
- Mitochondrial modulators for bipolar Disorder: A pathophysiologically informed paradigm for new drug development.
- Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive Disorder, and their impact on response to fluoxetine treatment.
- Advancing the treatment of depression with personalized medicine.
- Response to blier letter.
- Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report.
- Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar Disorder.
- Mindfulness-based cognitive therapy for bipolar Disorder: effects on cognitive functioning.
- Stepping back to step forward: lessons from the systematic treatment enhancement program for bipolar Disorder (STEP-BD).
- Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance ...
- Sleep disturbance in euthymic Bipolar patients.
- Norms for Performance in the Workplace in Healthy People: Data from the National Comorbidity Survey Replication Study.
- Dr Nierenberg replies.
- Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk.
- Concise associated symptoms tracking scale: a brief self-report and clinician rating of symptoms associated with suicidality.
- Response rates to fluoxetine in subjects who initially show no improvement.
- Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive Disorder...
- Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study.
- Development of an integrated psychosocial treatment to address the medical burden associated with bipolar Disorder.
- Customization in prescribing for bipolar Disorder.
- Mindfulness-based cognitive therapy for nonremitted patients with bipolar Disorder.
- Longitudinal Follow-Up of Bipolar Disorder in Women With Premenstrual Exacerbation: Findings From STEP-BD.
- Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication.
- Crisis of confidence: antidepressant risk versus benefit.
- A critical review of pharmacotherapy for major depressive Disorder.
- Residual symptoms after remission of major depressive Disorder with fluoxetine and risk of relapse.
- Alternatives to antidepressants in treating acute Bipolar depression.
- The current crisis of confidence in antidepressants.
- Switch or augment? Lessons from STAR*D.
- My Mother's Levetiracetam.
- Psychoticism and paranoid ideation in patients with nonpsychotic major depressive Disorder: prevalence, response to treatment, and impact on short- and long-term treat...
- The influence of menopause status and postmenopausal use of hormone therapy on presentation of Major depression in women.
- Are we losing our minds?
- The Congressional antidepressant hearings: exploring the relationship between medication and veteran suicide.
- The perfect storm: CNS drug development in trouble.
- One size fits none? Treatment algorithms and guidelines in psychiatry and neurology.
- Assuring that double-blind is blind.
- Clinical features associated with poor pharmacologic adherence in bipolar Disorder: results from the STEP-BD study.
- Antidepressants: can't live with them, can't live without them.
- Benzodiazepine use and risk of recurrence in bipolar Disorder: a STEP-BD report.
- Health-related quality of life in depression: a STAR*D report.
- Hopes and dreams: healthcare reform and comparative effectiveness research for personalized treatment in psychiatry and neurology.
- Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I Disorder susceptibility locus.
- Review of medication adherence in children and adults with ADHD.
- Something borrowed, something blue: why is bipolar Disorder an orphan?
- Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar Disorder.
- Baseline disability and poor functioning in bipolar Disorder predict worse outcomes: results from the Bipolar CHOICE study.
Schools
Albert Einstein College of Medicine of Yeshiva University
Nyu Med Center Bellevue Hospital
Yale University
Conditions Treated
- Adjustment Disorder
- Bipolar Disorder
- Major Depressive Disorder
- Post-Traumatic Stress Disorder (PTSD)
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
NYU School of Medicine -
Albert Einstein College of Medicine of Yeshiva University
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1336113661 | |
| NPPES Provider LastName | NIERENBERG | |
| NPPES Provider FirstName | ANDREW | |
| NPPES Provider ZIPCode | 021142517 | |
| NPPES Provider State | MA | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 256.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1336113661 |
| Last Name Of The Provider | NIERENBERG |
| First Name Of The Provider | ANDREW |
| View All |
Similar Doctors
|
|
Dr. Scott N. Wilson, MD |
|
|
Dr. Joanna Bures, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Waldinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Osarumen N. Nomamiukor, MD |
|
|
Dr. Daniel J. Zimmerman, MD |
|
|
Dr. Julia R. Lustick, MD |
|
|
Dr. Elizabeth D. Alfson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina M. Dording, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christie L. Sams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karina A. Stone, MD |
|
|
Dr. Rebecca L. Peak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yohanis L. Anglero Diaz, MD |
|
|
Dr. Sanja Petrovic-Stojkovic, MD |